News & Press Releases
Filter by:
Hsu Untied Interview with Steve Osborn
January 31, 2024
Podcaster Richard Hsu interviewed San Francisco Managing Member Steve Osborn on his podcast Hsu Untied. In the episode, Steve reflects on his career journey, including his start in law school to becoming an attorney advising on international work in London and Hong Kong, and his rise from launching a boutique firm to his current role as a tech and life sciences-focused Managing Member. Steve also highlights the importance of calculated risks for professional growth.
Mintz Facilitates $3.7 Billion Deal For The Cigna Group
January 31, 2024
The Cigna Health Group signed a deal selling its Medicare businesses to Health Care Service Corporation (HCSC) for $3.7 billion. A Mintz team led by Tara Dwyer and Lauren Moldawer acted as regulatory counsel to The Cigna Group on the sale. In the deal, which is expected to close in the first quarter of 2025, HCSC will acquire Cigna’s Medicare lines including Medicare Advantage, Medicare supplement, and Medicare drug plans, as well as CareAllies, a unit that works with physician groups and other healthcare providers.
Mintz Advises Cultivo in $14M Series A Funding
January 31, 2024
A Mintz team led by Tom Burton and Alex Civetta advised Cultivo Land PBC on its recent $14 million Series A funding round, bringing the company to over $20 million. This investment will be used to advance the growth of Cultivo’s AI platform for large scale nature regeneration projects, specifically focused on carbon removal, biodiversity enhancement, and improved water storage.
401k Plan Sponsors Must Be Wary Of Fiduciary Liability Associated With Bitcoin ETFs
January 30, 2024
Fiduciary News spoke to Of Counsel Michelle Capezza on the impact of the SEC’s approval of the creation of Bitcoin ETFs on 401k plan sponsors.
Senator's Hold on FTC Nominee Robs Agency of Political Diversity, Regulatory Attorneys Say
January 29, 2024
Antitrust Co-Chair Bruce Sokler shared his insights with the National Law Journal on Andrew Ferguson and Melissa Holyoak’s nominations to the Federal Trade Comission. Bruce acknowledged that both Ferguson and Holyoak have state-level experience, which could be a “useful perspective” on the commission.
What You Need to Know About FDA's Proposed Regulation of LDTs
January 26, 2024
MDDI interviewed Of Counsel Benjamin Zegarelli on the controversy surrounding the FDA’s proposed regulation to oversee laboratory-developed tests (LDT) and his thoughts on the future of LDTs.
Press Contact